Erythema nodosum and serological lupus erythematosus. Simultaneous occurrence in a patient using oral contraceptives.
D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004893:Erythema Nodosum / Q000139:chemically induced* / Q000150:complications / Q000276:immunology / Q000473:pathology; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005040:Ethynodiol Diacetate / Q000009:adverse effects; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000150:complications / Q000276:immunology; D008297:Male; D009504:Neutrophils; D010587:Phagocytosis
D000974:Antibodies, Antinuclear; D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D003165:Complement System Proteins